Derived from Latin, the notion “in vitro diagnostics” refers to tests such as blood, tissues, or urine tests that are carried out in controlled environment outside a living organism. In vitro diagnostics tests are usually held in a laboratory, while sometimes they are carried out at home. In vitro diagnostics is used in hematology, clinical chemistry, molecular diagnostics, immunology, etc.
Development of technologies, the growing incidence of respiratory, sexually transmitted diseases are among the top factors contributing to the market growth. In vitro diagnostics gains popularity worldwide and the market grows swiftly, especially in developing countries such as India and China. Alere Inc, Beckman Coulter Inc and Diasorin Diagnostic S.P.A. are amidst majors are active in the in vitro diagnostics market.
The Catalogue includes research reports offering cutting-edge data on the market for in vitro diagnostics. The reports provide analyses market’s drivers and restraints. The research studies contain profiles of leading market participants. Overviews of the competitive landscape and technologies are available in the reports too.
Publications found:
45,650
Sort by:
Global Drug Abuse Testing Market - 2025-2033
US$ 3,400.00
Global Drug Abuse Testing Market reached US$ 7.26 billion in 2023 and is expected to reach US$ 12.31 billion by 2033, growing with a CAGR of 5.30% during the forecast period 2026-2033. The Global Drug...
January 2025
51 pages
Blood Banking Equipment Market Forecasts to 2030 – Global Analysis by Product (Blood Collection Devices, Blood Processing Equipment, Blood Storage Equipment, Blood Testing Equipment and Other Products), Mode of Collection, Application, End User and By Geography
US$ 4,150.00
According to Stratistics MRC, the Global Blood Banking Equipment Market is accounted for $16,322.1 million in 2024 and is expected to reach $23,950.7 million by 2030 growing at a CAGR of 6.6% during t...
January 2025
150 pages
Cardiac Biomarkers Market Size, Share, and Analysis, By Type (Creatine Kinase-MB (CK-MB), Troponin, B-type Natriuretic Peptide (BNP), N-terminal Pro-BNP (NT-proBNP), and Others), By Application (Acute Coronary Syndrome, Myocardial Infarction, Congestive Heart Failure, and Others), By End User (Hospitals, Point of Care Testing, Laboratory Testing, Diagnostic Centers), By Region (North America, Europe, Asia-Pacific, and Rest of the World), And Regional Forecast 2024-2034
US$ 5,250.00
Cardiac Biomarkers Market is projected to exhibit a Compound Annual Growth Rate (CAGR) of 13.8% during the forecast span from 2024 to 2034. In 2023, the market size was assessed at USD 13.9 billion an...
January 2025
524 pages
2024-2029 Africa Endocrine Function Testing Market for 20 Assays - Opportunities in 7 Countries, 2024 Supplier Shares and Strategies, 2024-2029 Volume and Sales Segment Forecasts, Latest Technologies and Instrumentation Pipeline, Market Barriers and Risks
US$ 4,500.00
This new report from LeadingMarketResearch.com provides analysis of the endocrine function diagnostics market, including emerging tests, technologies, instrumentation, sales forecasts, market shares a...
December 2024
-
2024-2029 Asia-Pacific Endocrine Function Testing Market for 20 Assays - Opportunities in 18 Countries, 2024 Supplier Shares and Strategies, 2024-2029 Volume and Sales Segment Forecasts, Latest Technologies and Instrumentation Pipeline, Market Barriers and Risks
US$ 9,500.00
This new report from LeadingMarketResearch.com provides analysis of the endocrine function diagnostics market, including emerging tests, technologies, instrumentation, sales forecasts, market shares a...
December 2024
-
